在儿科脏病学中使用瑞图西马布:从2003年到2024年的图书法和可视化分析
1Department of Pediatrics, Guangzhou First People's Hospital, Guangdong Medical University, Zhanjiang, Guangdong, China.
Critical reviews in eukaryotic gene expression
|December 22, 2025
概括
图书统计分析显示,使用Rituximab (RTX) 治疗儿科脏疾病的研究趋势越来越大. 这突出了RTX的特点.
科学领域:
- 儿科脏病学 儿科脏病学
- 免疫抑制疗法 免疫抑制疗法
- 图书统计分析 图书统计分析
背景情况:
- 利图西马布 (RTX) 越来越多地用于治疗儿科病.
- 了解RTX在该领域的研究环境对于确定趋势和未来方向至关重要.
研究的目的:
- 在儿科病治疗中进行RTX的图库计量和可视化分析.
- 识别研究热点,关键贡献者和这一治疗领域的新兴趋势.
主要方法:
- 科学网络核心集合的文献搜索.
- 从2003-2024年英语论文和评论的选择.
- 使用VOSviewer,CiteSpace和Bibliometrix进行图书法分析.
主要成果:
- 来自54个国家的2,797名研究人员发表了525篇文章.
- 美国在出版物方面处于领先地位;巴黎公共医院援助是一个领先的机构.
- 儿科脏病学和"柳叶刀"是著名的期刊;脏综合征是一个关键的研究重点.
结论:
- 出版物和引文的持续增长表明RTX对儿科病治疗的重大影响.
- 这项研究为研究人员提供了有关当前研究热点和未来趋势的见解.
- 这些发现强调了RTX在治疗儿科病的重要性和潜力.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
191
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
191
Pharmacokinetics in Pediatric Patients: Drug Distribution
234
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
234
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
225
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
225
Pharmacokinetics in Pediatric Patients: Drug Metabolism
171
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
171
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
166
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
166
Renal Drug Clearance: Overview
635
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
635


